Work

Biodegradable, Microstructured, Electroconductive and Nano-integrated Drug-Eluting patch (MENDEP): A Translational Myocardial Tissue Engineering approach to post-ischemic Heart Failure prevention

Type: dissertation
Abstract: Heart failure (HF) remains a leading global cause of mortality, with myocardial infarction (MI) as its primary cause.MI results from coronary artery occlusion, triggering massive cardiomyocyte death and extracellular matrix degradation.The ensuing adverse left ventricular remodelling often progresses to post-ischemic HF if left untreated.Despite advances in pharmacological and interventional therapies, no current treatment can restore or regenerate functional myocardial tissue.Owing to the limited regenerative capacity of the adult heart, existing strategies mainly mitigate symptoms without preventing long-term deterioration.This research focused on the design, characterization and biological evaluation of MENDEP (Microstructured, Electroconductive and Nano-functionalized Drug-Eluting cardiac Patch), an acellular engineered scaffold conceived to counteract the structural and functional deterioration of myocardial tissue after infarction.MENDEP exhibited mechanical anisotropy and biaxial strength comparable to native porcine myocardium, reduced impedance, controlled biodegradability, specific molecular recognition capacity and sustained drug release.In vitro, MENDEP demonstrated cytocompatibility while migration assays verified the chemoattractive potential of the scaffold toward endogenous precursor cells.MENDEP was then epicardially implanted in a rat model of ischemia/reperfusion (I/R).Histological and immunofluorescence analyses indicated that implantation did not cause damage to the healthy myocardium.After I/R, MENDEP recruited precursor cells into the damaged myocardium and triggered their differentiation towards the vascular lineage.Under the patch, the myocardial tissue appeared well preserved.The fibrotic area measured in the I/R group was partially reduced in the patch group.The acellular and off-the-shelf nature of MENDEP, combined with its demonstrated safety and efficacy potential, underscores its translational relevance.This work also contributed to the establishment of the academic spinoff Impavid S.r.l., dedicated to advancing MENDEP toward large-animal validation and eventual clinical translation.Overall, the results highlight MENDEP as a promising therapeutic platform capable of modulating key biological drivers of post-ischemic heart failure, promoting myocardial preservation and regeneration after MI.
Institution: University of Turin
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W7216711988
Cites: 315
Cited by:
Related to: 10